Poseida Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018
Market Capitalization	208	321	456	426	678	-	-
Market Cap Growth	-	-29.47%	7.02%	-37.23%	-	-	-
Enterprise Value	82	195	262	281	428	-96	-11
PE Ratio	-2.60	-2.60	-7.12	-3.41	-5.23	-	-
PS Ratio	3.22	4.97	3.49	13.63	-	-	-
PB Ratio	2.01	3.10	2.43	2.73	2.59	-	-
P/FCF Ratio	-3.37	-3.37	-14.85	-4.05	-5.21	-	-
P/OCF Ratio	-3.49	-3.49	-17.02	-4.15	-5.98	-	-
EV/Sales Ratio	1.26	3.01	2.01	8.98	-	-	-
EV/EBITDA Ratio	-1.78	-1.78	-5.04	-2.40	-3.46	1.18	0.27
EV/EBIT Ratio	-1.70	-1.70	-4.59	-2.31	-3.39	1.16	0.26
EV/FCF Ratio	-2.04	-2.04	-8.53	-2.67	-3.29	1.38	0.29
Debt / Equity Ratio	0.82	0.82	0.47	0.39	0.23	-0.19	-0.25
Debt / EBITDA Ratio	-0.78	-0.78	-1.71	-0.52	-0.48	-0.36	-0.45
Debt / FCF Ratio	-0.90	-0.90	-2.89	-0.58	-0.46	-0.42	-0.49
Quick Ratio	3.10	3.10	5.41	4.76	10.30	5.73	2.33
Current Ratio	3.18	3.18	5.54	4.93	10.46	5.82	2.51
Asset Turnover	0.22	0.22	0.44	0.11	0	0	-
Interest Coverage	-13.22	-13.22	-8.96	-36.22	-36.02	-23.35	-23.84
Return on Equity (ROE)	-94.90%	-94.90%	-44.60%	-69.40%	-230.80%	76.50%	-
Return on Assets (ROA)	-42.20%	-42.20%	-21.60%	-43.00%	-50.10%	-90.10%	-
Return on Capital (ROIC)	-68.48%	-68.48%	-21.69%	-65.04%	-39.39%	71.06%	72.86%
Earnings Yield	-59.22%	-38.42%	-14.05%	-29.36%	-19.14%	-	-
FCF Yield	-45.69%	-29.64%	-6.74%	-24.70%	-19.20%	-	-
Buyback Yield / Dilution	-25.34%	-25.34%	-15.61%	-72.89%	-185.27%	-3.57%	-
Total Shareholder Return	-25.34%	-25.34%	-15.61%	-72.89%	-185.27%	-3.57%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).